BridgeMD
New treatment option for Carpal Tunnel Syndrome
Official title Carpal Arch Space Augmentation (CASA) Clinical Trial
ClinicalTrials.gov ID: NCT06208709
What this study is testing
- What it's testing
- This research proposes to evaluate the effectiveness of a novel device designed for the treatment of carpal tunnel syndrome. The device applies a small cyclic force to the wrist.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- 18 and older
- Diagnosed with right-handed or bilateral CTS. Participants will be treated only in the right hand.
You likely can't join if
- History of musculoskeletal or neurological conditions that may confound Carpal Tunnel Syndrome symptoms, including but not limited to:
- Diagnosed or suspected arthritis in the test wrist, hand, or finger joints
- Prior neck trauma, whiplash injury, or any condition suggestive of cervical radiculopathy
- Current or prior treatment from a healthcare provider such as neurologist, physical therapist, physiatrist, rheumatologist, neurosurgeon, orthopedic...
- History of traumatic or chronic symptomatic neuromusculoskeletal disorders involving the upper extremity to be tested.
- The following diseases: uncontrolled diabetes, thyroid disease, rheumatoid arthritis, gout, lupus, renal failure, hemodialysis, sarcoidosis...
See the full eligibility criteria
- 18 and older
- Diagnosed with right-handed or bilateral CTS. Participants will be treated only in the right hand.
- History of musculoskeletal or neurological conditions that may confound Carpal Tunnel Syndrome symptoms, including but not limited to:
- Diagnosed or suspected arthritis in the test wrist, hand, or finger joints
- Prior neck trauma, whiplash injury, or any condition suggestive of cervical radiculopathy
- Current or prior treatment from a healthcare provider such as neurologist, physical therapist, physiatrist, rheumatologist, neurosurgeon, orthopedic surgeon or chiropractor for cervical radiculopathy or other...
- History of traumatic or chronic symptomatic neuromusculoskeletal disorders involving the upper extremity to be tested.
- The following diseases: uncontrolled diabetes, thyroid disease, rheumatoid arthritis, gout, lupus, renal failure, hemodialysis, sarcoidosis, amyloidosis, additional systemic diseases that may have an effect on the...
- Positive diagnosis of cervical disorders affecting the same side of the body as the test hand such as radiculopathy, spondylosis, tumor, and multiple sclerosis
- Symptomatic joint diseases in the test hand (e.g., Osteoarthritis)
- Osteoporosis in the test hand
- History of carpal tunnel release in the test hand
- History of corticosteroid injection treatments for CTS in the test hand within the 3 months preceding study initiation
- Women who are currently pregnant
- Patients who have carpal tunnel release surgery scheduled for the next 12 weeks in their test hand.
- Patients who have taken pain medication, including over-the-counter products, within 2 weeks prior to initiation of the study.
- Will not participate in other CTS treatment or therapies during this study
The study team makes the final eligibility decision.
Where it's taking place
- Tucson, Arizona, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Tucson, Arizona, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.